News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Myricx Bio, a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), today announced the closing of its Ser...

Caroline Stanton, Head of SME Partnerships at The University of Manchester, shares how the institution is supporting innovative businesses to scale and grow through partnership and collabora...

Bruntwood SciTech is announcing the launch of its new Life Science Accelerator programme at Alderley Park in a move aimed at supporting even greater innovation and economic growth in the reg...

In his first decade as CEO at AstraZeneca, Pascal Soriot achieved one ambitious revenue goal. Now he shoots for another, targeting sales of $80 billion for the drugmaker by 2030.

Monument Therapeutics, a precision neuroscience company, today announced new funding of £1.5 million from a combination of equity investment and non-dilutive grant as part of the Innovate U...

Suffolk-based cleanroom construction specialists line up four massive shows in April, May and June

Drive critical engineering innovation in electrification and manufacturing with Newcastle University’s new Level 6 BEng Product Design and Development Engineer Degree Apprenticeship, with ...

Suffolk-based cleanroom design & build experts launch their fifth new subsite in the space of a yea

The pharmaceutical firm's investment will boost the UK's Life Sciences sector

Belfast-based techbio company AMPLY Discovery Limited has raised over £1.4m in grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.

The University of Liverpool has launched a new spin-out company, TrophiCell, that has developed a revolutionary approach to harness the therapeutic potential of adult Mesenchymal Stem Cells ...

Opportunity to access placement students to develop your talent pool

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners